Temporal Arteritis: Clinical Trials

2 trials for Temporal Arteritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 21Terminated 1

Follow Temporal Arteritis: new trials by email Literature Review of Temporal Arteritis trials Research Report on Temporal Arteritis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ustekinumab for the Treatment of Giant Cell Arteritis
Ustekinumab, Prednisone - Giant Cell Arteritis, Temporal Arteritis
Phase 1 / Phase 2TerminatedMassachusetts General Hospital132016-12-012020-06-12
MRI Superficial Temporal Artery
MRI - Temporal Arteritis
Phase 1CompletedUniversity Health Network, Toronto52003-04-012007-04-23

Narrower conditions

Giant Cell Arteritis (2)

Broader conditions

Arteritis (2)  ·  Autoimmune Diseases (2)  ·  Autoimmune Diseases of the Nervous System (2)  ·  Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Immune System Diseases (2)  ·  Nervous System Diseases (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Vascular (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Vascular Diseases (2)  ·  Vasculitis (2)  ·  Vasculitis, Central Nervous System (2)

Interventions

Prednisone (1)  ·  Ustekinumab (1)

Sponsors

Massachusetts General Hospital (1)  ·  University Health Network, Toronto (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Narinder Paul, FRCP C (1)

Results publications

PMID 32248659